Citation: Ejf. Demant et E. Friche, KINETICS OF ANTHRACYCLINE ACCUMULATION IN MULTIDRUG-RESISTANT TUMOR-CELLS - RELATIONSHIP TO DRUG LIPOPHILICITY AND SERUM-ALBUMIN BINDING, Biochemical pharmacology, 56(9), 1998, pp. 1209-1217
Citation: Ejf. Demant et E. Friche, EQUILIBRIUM BINDING OF ANTHRACYCLINE CYTOSTATICS TO SERUM-ALBUMIN ANDSMALL UNILAMELLAR PHOSPHOLIPID-VESICLES AS MEASURED BY GEL-FILTRATION, Biochemical pharmacology, 55(1), 1998, pp. 27-32
Authors:
NIELSEN D
MAARE C
LITMAN T
KJAERSGAARD E
PLESNER T
FRICHE E
ERIKSEN J
SKOVSGAARD T
Citation: D. Nielsen et al., CHARACTERIZATION OF MULTIDRUG-RESISTANT EHRLICH ASCITES TUMOR-CELLS (EHR2) SELECTED FOR RESISTANCE TO MITOXANTRONE (MITOX), European journal of cancer, 33, 1997, pp. 797-797
Citation: E. Friche et al., INSTANT UP-REGULATION OF P-GLYCOPROTEIN (PGP) BY VINCRISTINE (VCR) AND DAUNORUBICIN (DNR) IN MULTIDRUG-RESISTANT CEM T-LYMPHOBLASTIC SUBLINES, Blood, 90(10), 1997, pp. 3638-3638
Authors:
RASMUSSEN J
HANSEN LL
FRICHE E
JAROSZEWSKI JW
Citation: J. Rasmussen et al., P-31 AND C-13 NMR SPECTROSCOPIC STUDY OF WILD-TYPE AND MULTIDRUG-RESISTANT EHRLICH ASCITES TUMOR-CELLS, Oncology research, 5(3), 1993, pp. 119-126
Authors:
SEHESTED M
JENSEN PB
SORENSEN BS
HOLM B
FRICHE E
DEMANT EJF
Citation: M. Sehested et al., ANTAGONISTIC EFFECT OF THE CARDIOPROTECTOR (-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187) ON DNA BREAKS AND CYTOTOXICITY INDUCED BYTHE TOPOISOMERASE-II DIRECTED DRUGS DAUNORUBICIN AND ETOPOSIDE (VP-16)()), Biochemical pharmacology, 46(3), 1993, pp. 389-393
Authors:
JENSEN PB
SORENSEN BS
SEHESTED M
DEMANT EJF
KJELDSEN E
FRICHE E
HANSEN HH
Citation: Pb. Jensen et al., DIFFERENT MODES OF ANTHRACYCLINE INTERACTION WITH TOPOISOMERASE-II-SEPARATE STRUCTURES CRITICAL FOR DNA-CLEAVAGE, AND FOR OVERCOMING TOPOISOMERASE-II-RELATED DRUG-RESISTANCE, Biochemical pharmacology, 45(10), 1993, pp. 2025-2035
Authors:
HANSEN LL
RASMUSSEN J
FRICHE E
JAROSZEWSKI JW
Citation: Ll. Hansen et al., METHOD FOR DETERMINATION OF INTRACELLULAR SODIUM IN PERFUSED CANCER-CELLS BY NA-23 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY, Analytical biochemistry, 214(2), 1993, pp. 506-510